Efficacy of olanzapine combined with the standard triplet antiemetic therapy for cisplatin-based chemotherapy: A sub-analysis of a randomized, double-blind, placebo-controlled trial (J-FORCE).

Yukiyoshi Fujita,Masakazu Abe,Takuhiro Yamaguchi,Hiroki Ueda,Koichi Kitagawa,Jun Okamura,Katsuya Hirano,Yukio Sakata,Hirotoshi Iihara,Yasuhiro Shimada,Takeshi Aoyama,Kazuhiko Shibata,Kensuke Hori,Haruko Daga,Toshiaki Nakayama,Yasuhiko Sakata,Sadamoto Zenda,Hironobu Hashimoto

Efficacy of olanzapine combined with the standard triplet antiemetic therapy for cisplatin-based chemotherapy: A sub-analysis of a randomized, double-blind, placebo-controlled trial (J-FORCE).

2021

Yukiyoshi Fujita
Masakazu Abe
Takuhiro Yamaguchi
Hiroki Ueda
Koichi Kitagawa
Jun Okamura
Katsuya Hirano
Yukio Sakata
Hirotoshi Iihara
Yasuhiro Shimada
Takeshi Aoyama
Kazuhiko Shibata
Kensuke Hori
Haruko Daga
Toshiaki Nakayama
Yasuhiko Sakata
Sadamoto Zenda
Hironobu Hashimoto

12098Background: In a randomized, double-blind, placebo-controlled trial (J-FORCE), we previously reported the efficacy of olanzapine (OLZ) 5 mg plus triplet antiemetic therapy for cisplatin (CDDP)...

Keywords:

Medicine
Internal medicine
cisplatin based chemotherapy
Olanzapine
Oncology
Antiemetic
double blind
Cisplatin
Placebo-controlled study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations